MEDTHERAPY

Serial Number 98071706
760

Registration Progress

Application Filed
Jul 5, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

MEDTHERAPY

Basic Information

Serial Number
98071706
Filing Date
July 5, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
760
Status Date
Apr 18, 2025
Application
Pending
Classes
042

Rights Holder

Medtherapy Biotechnology Inc.

03
Address
1250 Hancock Street
Quincy, MA 02169

Ownership History

Medtherapy Biotechnology Inc.

Original Applicant
03
Quincy, MA

Legal Representation

Attorney
Anthony Laurentano

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

26 events
Date Code Type Description Documents
Apr 11, 2025 GEA1 O NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED Loading...
Apr 11, 2025 GECD O ACTION DENYING REQ FOR RECON E-MAILED Loading...
Apr 11, 2025 CNCF S ACTION CONTINUING FINAL - COMPLETED Loading...
Mar 25, 2025 ALIE A ASSIGNED TO LIE Loading...
Mar 25, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 25, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 7, 2025 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Mar 7, 2025 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Mar 7, 2025 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Mar 7, 2025 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Feb 4, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Feb 4, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Nov 25, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 25, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Nov 25, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Sep 7, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 18, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jun 18, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Mar 25, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 25, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 25, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 17, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 4, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 8, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research services; research and development of cancer pharmaceuticals

Additional Information

Pseudo Mark
MEDICAL THERAPY

Classification

International Classes
042